Flagship Harbor Advisors’s ARK Genomic Revolution ETF ARKG Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q3 | – | Sell |
-6,379
| Closed | -$201K | – | 587 |
|
|
2022
Q2 | $201K | Buy |
6,379
+160
| +3% | +$5.04K | 0.02% | 563 |
|
|
2022
Q1 | $286K | Buy |
+6,219
| New | +$286K | 0.03% | 497 |
|
|
2021
Q2 | – | Sell |
-6,182
| Closed | -$549K | – | 628 |
|
|
2021
Q1 | $549K | Buy |
6,182
+436
| +8% | +$38.7K | 0.06% | 321 |
|
|
2020
Q4 | $536K | Buy |
5,746
+567
| +11% | +$52.9K | 0.07% | 289 |
|
|
2020
Q3 | $330K | Buy |
5,179
+1,359
| +36% | +$86.6K | 0.04% | 341 |
|
|
2020
Q2 | $199K | Buy |
3,820
+1,111
| +41% | +$57.9K | 0.03% | 461 |
|
|
2020
Q1 | $85K | Sell |
2,709
-174
| -6% | -$5.46K | 0.02% | 594 |
|
|
2019
Q4 | $97K | Buy |
2,883
+12
| +0.4% | +$404 | 0.02% | 613 |
|
|
2019
Q3 | $84K | Sell |
2,871
-200
| -7% | -$5.85K | 0.02% | 632 |
|
|
2019
Q2 | $105K | Buy |
3,071
+100
| +3% | +$3.42K | 0.02% | 553 |
|
|
2019
Q1 | $97K | Buy |
2,971
+471
| +19% | +$15.4K | 0.02% | 569 |
|
|
2018
Q4 | $59K | Buy |
2,500
+2,100
| +525% | +$49.6K | 0.01% | 652 |
|
|
2018
Q3 | $13K | Buy |
+400
| New | +$13K | ﹤0.01% | 1284 |
|